A front-of-package food label would be a great educational tool. The Trump administration should keep it.
By Melissa Patrick Kentucky Health News The U.S. Food and Drug Administration has banned Red Dye No. 3 from food, beverages and drugs. The Center for Science in the Public Interest, which brought the petition to ban red No.
The Food and Drug Administration announced last week that it will revoke authorization for FD&C Red No. 3 in food and ingested drugs under the Delaney Clause of the Federal Food, Drug, and Cosmetic Act. Red No. 3, a synthetic food dye, gives products like candies, frosting and frozen desserts their bright, cherry-red color.
The FDA revokes FD&C Red No. 3 authorization due to cancer concerns under the Delaney Clause, impacting food and drug manufacturers.
NORTH DAKOTA ( KXNET) — On Wednesday, the Food and Drug Administration announced the ban of Red No. 3. This is a synthetic dye that gives food and drinks a bright cherry-red color, which has been linked in tests to cancer in laboratory animals.
Now that the US Food and Drug Administration has banned red dye No. 3 ... principal scientist of food additives and supplements at the Center for Science in the Public Interest. That assessment included all the artificial food dyes — not just red ...
The FDA has passed a ban on Red No. 3, which is used in everything from milk to candy to cough syrup, after animal studies linked the food additive to cancer.
On January 16, 2025, the U.S. Food and Drug Administration (“FDA”) published a highly anticipated proposed rule on front-of-package (“FOP”)
The FDA banned Red Dye No. 3. The additive is found in over 9,000 U.S. products. Here’s how to avoid it, and what to reach for instead.
In a Senate hearing, Robert F. Kennedy, Jr. said that efforts to address the high rates of chronic disease need to start with fixing the food supply.
Doctors take an oath to “do no harm.” That sadly doesn’t apply to the Trump administration officials who have thrown America’s medical research into chaos by freezing funds, halting grants and banning travel.
FDA faces radical changes under Trump, risking public health and regulatory stability. • Trump reinstates the “Schedule F” order, threatening federal employees’ job security and increasing political influence over regulatory decisions.